Angiotensin II type 1 receptor blockade after cardiac transplantation reduced the incidence and severity of transplant vasculopathy in an animal-based study

Transplant Proc. 2002 Aug;34(5):1484-5. doi: 10.1016/s0041-1345(02)02940-8.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Angiotensin Receptor Antagonists*
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Animals
  • Coronary Disease / prevention & control*
  • Enalapril / pharmacology
  • Heart Transplantation / pathology
  • Heart Transplantation / physiology*
  • Losartan / pharmacology*
  • Models, Animal
  • Postoperative Complications / prevention & control
  • Rats
  • Rats, Inbred F344
  • Rats, Inbred Lew
  • Receptor, Angiotensin, Type 1
  • Vascular Diseases / prevention & control*

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Receptor, Angiotensin, Type 1
  • Enalapril
  • Losartan